Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,710
-280 (-2.55%)
Jun 4, 2026, 2:35 PM KST

KRX:271980 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
53,46948,87453,47632,99131,44625,963
Short-Term Investments
7,9554,2693,9802,667142.462,040
Trading Asset Securities
5,5345,689----
Cash & Short-Term Investments
66,95958,83257,45535,65831,58928,003
Cash Growth
30.25%2.40%61.13%12.88%12.80%325.06%
Accounts Receivable
137,646136,848160,467150,955137,807129,424
Other Receivables
6,0134,13613,44015,17115,45415,265
Receivables
143,659140,984173,908166,126153,262146,689
Inventory
104,905104,475104,427109,76899,151102,458
Prepaid Expenses
351.31515.62214.62327.84291.88186.71
Other Current Assets
7,5486,8167,0315,1677,3487,336
Total Current Assets
323,422311,621343,036317,046291,641284,672
Property, Plant & Equipment
147,003147,726146,166137,041138,402125,710
Long-Term Investments
16,60225,0168,3427,3436,7985,032
Other Intangible Assets
8,7178,8544,9944,3203,8883,762
Long-Term Accounts Receivable
-0-00-000
Long-Term Deferred Tax Assets
11,8199,2597,4285,359172.391,452
Long-Term Deferred Charges
6,1346,5838,3788,5615,494-
Other Long-Term Assets
1,4461,5157,3567,65610,4965,858
Total Assets
515,144510,575525,700487,326456,892426,486
Accounts Payable
75,72289,019134,562144,338151,641153,084
Accrued Expenses
166.73170.84178.21160.7499.9129.33
Short-Term Debt
94,77690,48771,00064,77240,57624,166
Current Portion of Long-Term Debt
----2,5006,125
Current Portion of Leases
1,8291,8451,9711,9461,8321,915
Current Income Taxes Payable
3,6381,7943,588448.241,049114.57
Other Current Liabilities
63,43459,13780,39192,71062,66736,509
Total Current Liabilities
239,566242,454291,690304,375260,366221,943
Long-Term Debt
----3,9998,977
Long-Term Leases
770.581,0842,7254,4525,4436,617
Pension & Post-Retirement Benefits
17,26215,91811,7716,73325.041,262
Other Long-Term Liabilities
94.1194.11197.01938.5223,17020,339
Total Liabilities
257,692259,549306,383316,499293,003259,139
Common Stock
7,3527,3527,3527,3527,3527,352
Additional Paid-In Capital
204,141206,399206,223155,296155,296155,296
Retained Earnings
-29,645-29,336-52,296-19,660-20,321-10,414
Treasury Stock
--4,829-4,829-4,829-4,829-4,432
Comprehensive Income & Other
31,41431,48431,69920,41020,41020,410
Total Common Equity
213,262211,071188,150158,570157,909168,213
Minority Interest
44,19039,95431,167-1,538-2,312-866.16
Shareholders' Equity
257,452251,025219,317170,828163,889167,347
Total Liabilities & Equity
515,144510,575525,700487,326456,892426,486
Total Debt
97,37693,41675,69571,17054,35047,800
Net Cash (Debt)
-30,417-34,585-18,240-35,513-22,761-19,797
Net Cash Per Share
-2080.28-2373.44-1252.00-2437.13-1561.68-1355.11
Filing Date Shares Outstanding
14.7514.5714.5714.5714.5714.58
Total Common Shares Outstanding
14.7514.5714.5714.5714.5714.58
Working Capital
83,85669,16851,34512,67131,27562,729
Book Value Per Share
14455.7414485.2012912.1610882.2010836.8311533.52
Tangible Book Value
204,545202,217183,156154,250154,021164,451
Tangible Book Value Per Share
13864.8713877.5812569.4410585.7110570.0211275.56
Land
56,64954,46153,69840,61340,58630,106
Buildings
67,194107,964105,484103,864103,864102,213
Machinery
14,21293,16488,78788,62282,31576,560
Construction In Progress
-6,0824,7243,0703,7172,390